Arthrobacter globiformis - information sheet

Strain ATCC 8010

On this page

Overview

  • The Government of Canada conducted a science-based evaluation of Arthrobacter globiformis strain ATCC 8010, called a screening assessment, to address the potential for harm to Canadians and the environment.
  • Under the Canadian Environmental Protection Act, 1999 (CEPA 1999), the risk posed by a substance is determined by considering both its hazardous properties (its potential to cause adverse human health or ecological effects) and the amount of exposure there is to people or to the environment. A substance may have hazardous properties; however, the risk to human health or to the environment may be low depending upon the level of exposure.
  • Arthrobacter globiformis strain ATCC 8010 was estimated to have a low hazard toward both human health and the environment; and exposure to Canadians and the environment is low. Therefore, it is concluded that Arthrobacter globiformis strain ATCC 8010 is not harmful to human health or to the environment.

About this organism

  • This screening assessment focuses on the organism Arthrobacter globiformis strain ATCC 8010. This Priority C (lower hazard) organism was assessed as part of the micro-organisms initiative of the Chemicals Management Plan (CMP).
  • Arthrobacter globiformis strain ATCC 8010 is a bacteria that could have number of consumer, commercial and industrial uses. The characterisitics of Arthrobacter globiformis strain ATCC 8010 make it suitable for use in various applications including in food production, biocontrol, probiotic use in humans and animals, biodegradation, and water and wastewater treatment.
  • Arthrobacter globiformis strain ATCC 8010 has characteristics in common with other strains of the species Arthrobacter globiformis, which are found in nature.
  • Based on a 2009 survey, Arthrobacter globiformis strain ATCC 8010 was not reported to be manufactured in or imported into Canada.

Exposure of Canadians and the environment

  • According to information available to the Government of Canada, Canadians are not expected to be exposed to Arthrobacter globiformis strain ATCC 8010 nor is it expected to be released into the Canadian environment.

Key health and ecological effects (hazard)

  • There is no evidence in the scientific literature to suggest that Arthrobacter globiformis strain ATCC 8010 is likely to have adverse effects on human health.
  • In the unlikely event of infection, Arthrobacter globiformis strain ATCC 8010 is susceptible to clinically-relevant antibiotics.
  • Despite its widespread distribution and a history of use in aquatic invertebrates as a probiotic and in plants as a biocontrol agent, Arthrobacter globiformis strain ATCC 8010 has not been implicated in infections or other adverse effects in terrestrial and aquatic plants, vertebrates or invertebrates.

Risk assessment outcomes

  • Considering all information presented in this assessment, the risk to human health from Arthrobacter globiformis strain ATCC 8010 is low.
  • Also considering all information presented, there is low risk of harm to organisms and the broader integrity of the environment from Arthrobacter globiformis strain ATCC 8010.
  • The Government of Canada published the Final Screening Assessment for Arthrobacter Globiformis Strain ATCC 8010 on February 24, 2018.

Screening assessment conclusions

  • As a result of this screening assessment, the Government concluded that Arthrobacter globiformis strain ATCC 8010 is not harmful to human health at current levels of exposure.
  • The Government also concluded that Arthrobacter globiformis strain ATCC 8010 is not entering the environment at levels that may be harmful to the environment.

Preventive actions and reducing risk

  • The Government proposes that no further action under CEPA 1999 be taken on this organism in regards to potential risk to Canadians and to the environment.

Page details

Date modified: